Ludwig Institute for Cancer Research Limited

Jean-Charles Cerrottini

Pierre G Coulie

Donata Rimoldi

Daryl Reed

Victor Jongeneel

Stefan Carrel

Isolated cDNA molecules which encode the tumor rejection antigen precursor MAGE-10, the protein itself, antibodies to it, and uses of these are a part of the invention.

Immunogenic compositions of tumor rejection antigen precursor MAGE-10 and an adjuvant

Isolated cDNA molecules which encode the tumor rejection antigen precursor MAGE-10, the protein itself, antibodies to it, and uses of these are part of the invention.

MAGE-10 encoding CDNA, the tumor rejection antigen precursor MAGE-10, antibodies specific to the molecule, and uses thereof

Isolated cDNA molecules which encode the tumor rejection antigen precursor MAGE-10, the protein itself, antibodies to it, and uses of these are a part of the invention.1

MAGE-10 encoding cDNA, the tumor rejection antigen precursor MAGE-10, antibodies specific to the molecule, and uses thereof

Isolated tumor rejection antigen precursor MAGE-10 and compositions

Isolated CDNA molecules which encode the tumor rejection antigen precursor MAGE-10, the protein itself, antibodies to it, and uses of these are a part of the invention.1

Growing community of inventors

Epalinges, Switzerland

Jean-Charles Cerrottini